Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV, and HIV

Funded by the National Institute on Drug Abuse as a Center of Excellence


Learn about us Publications & Presentations Subscribe
Center for Health Economics of Treatment for Substance Users Is Established at Weill Cornell Medical College Read more

The Department of Health and Human Services has announced it will soon provide $485 million in grants to help states and territories combat the opioid crisis. The funding, which is the first of two rounds provided for in the 21st Century Cures Act, will be provided through State Targeted Response to the Opioid Crisis Grants […]

Read the full story

BLOG

Prescriber Mandates in Prescription Drug Monitoring Programs

by Yuhua Bao, PhD and Sarah Gutkind, MSPH

Evidence supports mandating registration To address the crisis of opioid misuse, abuse, and overdose, every state but Missouri has implemented a prescription drug monitoring program (PDMP) that collects data from retail pharmacies on all dispensed controlled substances. PDMPs can help prescribers identify patients who might misuse or divert controlled substances, as well as patients who […]

Read the blog post

BLOG

A Frightening Chart on Opioids

by Janet Weiner, PhD, MPH

The danger of that first prescription “Just in case,” the oral surgeon said, as he prescribed the opioid hydrocodone for my 17-year-old son, who just had his wisdom teeth out. “But you might try Motrin first,” he added. Not knowing what the next hours, or days, would bring, we filled the prescription for 20 pills. […]

Read the blog post

Dr. Bulat Idrisov is a National Institute on Drug Abuse (NIDA) International Program INVEST Drug Abuse Research Fellow under the mentorship of Dr. Jeffrey Samet, CHERISH HCV/HIV co-director. Dr. Idrisov completed his medical training in pediatrics and internal medicine in Russia and received a Fulbright Scholarship to complete his Master of Science in Global Health […]

Read the blog post

BLOG

Substituting Heroin for Prescription Opioids

by Janet Weiner, PhD, MPH

An unintended consequence of well-intentioned policy It seems self-evident: one way to address the epidemic of opioid deaths is to make prescription opioids harder to misuse. OxyContin, for example, is especially dangerous when it is crushed for ingestion, inhalation, or injection. In 2010, the FDA approved a reformulated, abuse-deterrent version of OxyContin that made the […]

Read the blog post

EVENT


CDUHR AIDS Seminar: Long-term Course of Opioid Addiction

Tuesday, May 9, 2017
10:30 am — 11:30 am
Yih-Ing Hser, PhD Director of the Center for Advancing Longitudinal Drug Abuse Research

Methodology

Experts in cost benefit, cost effectiveness, and budget impact analyses

Learn More Consultation Request

HCV and HIV

Experts in economic analysis of HCV and HIV and treatment among substance users

Learn More Consultation Request

Dissemination and Policy

Experts in disseminating health economic research among policy makers and the public

Learn More Latest Issue Brief

Pilot Grant and Training

Supports new investigators and investigators new to health economic research in substance use disorders, HCV, and HIV

Learn More Pilot Grants